Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01)

Grant Overview

Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01) is a research funding opportunity offered by National Institutes of Health covering areas such as Gene Therapy, Rare Disease, Neurology, Neuromuscular Disorders for applicants in United States, Foreign components allowed. The application deadline is October 8, 2027.

Researchers, universities, institutions and eligible organizations should review the funder requirements, geographic eligibility, research focus and deadline before preparing an application.